Difficulty: Medium
Average Score: 81%
Practice
Bone marrow responds to iron therapy by increasing erythropoietic activity. Which of the following in bone marrow would most likely indicate erythropoiesis?
Correct answer
B
Rationale
In the context of hematologic drugs and iron therapy, it is crucial to understand the physiological response of the bone marrow to increased erythropoietic activity. When bone marrow is stimulated to produce more red blood cells (erythropoiesis), one of the key indicators of this process is the presence of reticulocytes.
Reticulocytes are immature red blood cells that still contain remnants of ribosomal RNA. They are released into the bloodstream from the bone marrow in response to increased demand for oxygen-carrying red blood cells. Therefore, an increase in reticulocyte count indicates a robust erythropoietic response to iron therapy.
Analyzing the other options:
A) Myelocytes are immature white blood cells and are not specific indicators of erythropoiesis.
C) Ring sideroblasts are seen in certain types of anemia but are not direct indicators of active erythropoiesis.
D) Target cells are red blood cells with a characteristic target-like appearance due to excess membrane, seen in conditions like thalassemia, but they do not directly reflect active erythropoiesis.
Understanding these distinctions is vital for healthcare professionals prescribing hematologic drugs, as monitoring reticulocyte counts can help assess the effectiveness of iron therapy in stimulating red blood cell production. This knowledge is essential for accurate diagnosis and treatment of hematologic disorders, ensuring optimal patient care.
Reticulocytes are immature red blood cells that still contain remnants of ribosomal RNA. They are released into the bloodstream from the bone marrow in response to increased demand for oxygen-carrying red blood cells. Therefore, an increase in reticulocyte count indicates a robust erythropoietic response to iron therapy.
Analyzing the other options:
A) Myelocytes are immature white blood cells and are not specific indicators of erythropoiesis.
C) Ring sideroblasts are seen in certain types of anemia but are not direct indicators of active erythropoiesis.
D) Target cells are red blood cells with a characteristic target-like appearance due to excess membrane, seen in conditions like thalassemia, but they do not directly reflect active erythropoiesis.
Understanding these distinctions is vital for healthcare professionals prescribing hematologic drugs, as monitoring reticulocyte counts can help assess the effectiveness of iron therapy in stimulating red blood cell production. This knowledge is essential for accurate diagnosis and treatment of hematologic disorders, ensuring optimal patient care.